A more detailed CHMP meeting report will be published shortly. – ENDDoc. Ref: EMEA/116066/04 Download a PDF copy.Media inquiries only , please contact: Martin Harvey Allchurch, EMEA Spokeswoman Phone.
Starting the remedy providedThe CHMP two pan-European review process started in Article 30 of the Community code relating to medicinal products for human: – For a referral for Neurontin and associated names by by Italy harmonization of the different SPCs medicinal product in the European Union, in particular with regard to the default. Gabapentin in certain Member States in certain Member States for the treatment of partial epilepsy and neuropathic pain, and others only for the treatment of epilepsy..Atlantanfectious Diseases 2006 International Conference TheJournalists are invited to attend and cover in 2006 International Workshop on Emerging Infectious Diseases , held 19 to 22 Mar will will be at the Atlanta Marriott Marquis in Atlanta, Georgia. Of the by the Center for Disease Control and Prevention , from the American Society for Microbiology, the Council Heads of State and territoriality Epidemiologists, that Association of Public Health Laboratories and the World Health Organization.